Blood clots after heart. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy24

Heart Fetal Heart Blood Platelets Blood Heart Valves Heart Atria Myocardium Myocytes, Cardiac Heart Septum Autonomic Nervous System Sympathetic Nervous System Endocardium Plasma Cells, Cultured Sinoatrial Node Vagus Nerve Femoral Vein Kidney Atrioventricular Node Parasympathetic Nervous System Sarcolemma Pulmonary Artery Muscle, Skeletal Aorta

Organisms11

Rabbits Dogs Swine Rats, Sprague-Dawley Rats, Wistar Mice, Inbred C57BL Mice, Knockout Guinea Pigs Rats, Inbred Strains Cattle Animals, Newborn

Diseases54

Thrombosis Heart Failure Pulmonary Embolism Heart Diseases Blood Coagulation Disorders Heart Defects, Congenital Intracranial Embolism Cerebral Hemorrhage Subarachnoid Hemorrhage Disease Models, Animal Hemorrhage Heart Block Stroke Myocardial Ischemia Coronary Disease Cardiac Output, Low Myocardial Infarction Heart Failure, Systolic Cardiomyopathy, Dilated Cardiomegaly Heart Injuries Rheumatic Heart Disease Cardiomyopathies Myocardial Reperfusion Injury Heart Arrest Ventricular Dysfunction, Left Heart Failure, Diastolic Ventricular Remodeling Intracranial Thrombosis Chronic Disease Heart Septal Defects Hypoplastic Left Heart Syndrome Heart Neoplasms Cardiovascular Diseases Afibrinogenemia Heart Septal Defects, Ventricular Myocarditis Factor XIII Deficiency Acute Disease Hypertrophy, Left Ventricular Heart Septal Defects, Atrial Ventricular Dysfunction Intracranial Embolism and Thrombosis Venous Thrombosis Fibrosis Tachycardia Atrial Fibrillation Death, Sudden, Cardiac Thromboembolism Ventricular Fibrillation Body Weight Postoperative Complications Cyanosis Anoxia

Chemicals and Drugs57

Fibrin Tissue Plasminogen Activator Fibrinogen Factor XIIIa Hemostatics Fibrinolytic Agents Hemoglobin H Plasminogen alpha-2-Antiplasmin Fibrinolysin Factor XIII Thrombin Streptokinase Plasminogen Activators Heparin Recombinant Proteins Fibrinogens, Abnormal Cardiotonic Agents Carboxypeptidase U Adrenergic beta-Antagonists Fibrinopeptide B Fibrin Fibrinogen Degradation Products Natriuretic Peptide, Brain Biological Markers Calcium Urokinase-Type Plasminogen Activator Anticoagulants Batroxobin Isoproterenol Fibrinopeptide A Propanolamines Norepinephrine RNA, Messenger Anti-Arrhythmia Agents Coagulants Blood Coagulation Factors Thromboplastin Hirudins Hydroxyethyl Starch Derivatives Receptors, Adrenergic, beta Adrenergic beta-Agonists Vasodilator Agents Creatine Kinase Carboxypeptidase B Sarcoplasmic Reticulum Calcium-Transporting ATPases Propranolol Metoprolol Diuretics Platelet Glycoprotein GPIIb-IIIa Complex Pipecolic Acids Plasma Substitutes Peptide Fragments Polygeline Adenosine Triphosphate Digoxin Antifibrinolytic Agents Muscle Proteins

Analytical, Diagnostic and Therapeutic Techniques and Equipment65

Clot Retraction Thrombelastography Heart Rate Blood Coagulation Tests Ultrasonic Therapy High-Intensity Focused Ultrasound Ablation Heart Transplantation Thrombolytic Therapy Disease Models, Animal Fibrin Clot Lysis Time Treatment Outcome Heart Arrest, Induced Heart Function Tests Perfusion Heart, Artificial Risk Factors Stroke Volume Echocardiography Nephelometry and Turbidimetry Heart Valve Prosthesis Prospective Studies Follow-Up Studies Models, Cardiovascular Cardiac Pacing, Artificial Exercise Test Thrombin Time Retrospective Studies Predictive Value of Tests Prognosis Cohort Studies Risk Assessment Ischemic Preconditioning, Myocardial Mechanical Thrombolysis Heart-Assist Devices Electrocardiography, Ambulatory Whole Blood Coagulation Time Cardiac Surgical Procedures Severity of Illness Index Thrombectomy Microscopy, Electron, Scanning Reference Values Myocardial Reperfusion Heart Valve Prosthesis Implantation Models, Animal Case-Control Studies Double-Blind Method Cardiac Catheterization Echocardiography, Doppler Incidence Proportional Hazards Models Pacemaker, Artificial Reproducibility of Results Tomography, X-Ray Computed Hospitalization Embolectomy Sensitivity and Specificity Models, Biological Blood Flow Velocity Telemetry Bleeding Time Partial Thromboplastin Time Body Weight Survival Rate Cerebral Angiography Immunohistochemistry

Phenomena and Processes46

Clot Retraction Blood Coagulation Fibrinolysis Heart Rate Hemostasis Time Factors Platelet Activation Fibrin Clot Lysis Time Myocardial Contraction Kinetics Hemodynamics Ventricular Function, Left Heart Rate, Fetal Stroke Volume Ventricular Remodeling Oxygen Consumption Ventricular Pressure Thrombin Time Dose-Response Relationship, Drug Systole Diastole Platelet Aggregation Whole Blood Coagulation Time Baroreflex Signal Transduction Vascular Resistance Exercise Energy Metabolism Amino Acid Sequence Tissue Distribution Elasticity Aging Regional Blood Flow Sensitivity and Specificity Blood Flow Velocity Respiration Bleeding Time Action Potentials Partial Thromboplastin Time Body Weight Cardiovascular Physiological Phenomena Gene Expression Regulation, Developmental Gene Expression Cardiac Volume Organ Specificity Phenotype

Disciplines and Occupations2

Cardiology Immunohistochemistry

Anthropology, Education, Sociology and Social Phenomena2

National Heart, Lung, and Blood Institute (U.S.)Exercise

Technology, Industry, Agriculture1

Information Science5

Molecular Sequence Data Incidence Amino Acid Sequence Telemetry Survival Rate

Named Groups1

Infant, Newborn

Health Care21

Treatment Outcome Risk Factors Prospective Studies American Heart Association Follow-Up Studies National Heart, Lung, and Blood Institute (U.S.)Retrospective Studies Predictive Value of Tests Cohort Studies Risk Assessment Severity of Illness Index Case-Control Studies Age Factors Double-Blind Method Incidence Proportional Hazards Models Reproducibility of Results Hospitalization Sensitivity and Specificity Sex Factors Survival Rate

Geographicals1

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Anthropology, Education, Sociology and Social Phenomena Information Science Named Groups Health Care

Clot Retraction Blood Coagulation Heart Fibrin Fibrinolysis Thrombelastography Heart Rate Tissue Plasminogen Activator Thrombosis Fibrinogen Factor XIIIa Blood Coagulation Tests Ultrasonic Therapy Hemostatics Fibrinolytic Agents Heart Failure Hemoglobin H Plasminogen Pulmonary Embolism High-Intensity Focused Ultrasound Ablation Hemostasis alpha-2-Antiplasmin Fibrinolysin Factor XIII Heart Diseases Blood Coagulation Disorders Thrombin Heart Transplantation Heart Defects, Congenital Intracranial Embolism Cerebral Hemorrhage Streptokinase Thrombolytic Therapy Subarachnoid Hemorrhage Time Factors Fetal Heart Platelet Activation Rabbits Blood Platelets Dogs Blood Plasminogen Activators Disease Models, Animal Heart Valves Heparin Heart Atria Hemorrhage Recombinant Proteins Heart Block Fibrin Clot Lysis Time Treatment Outcome Myocardium Heart Arrest, Induced Stroke Heart Function Tests Myocardial Contraction Kinetics Myocardial Ischemia Myocytes, Cardiac Hemodynamics Swine Coronary Disease Cardiac Output, Low Ventricular Function, Left Perfusion Myocardial Infarction Heart, Artificial Fibrinogens, Abnormal Heart Failure, Systolic Risk Factors Cardiomyopathy, Dilated Cardiomegaly Heart Injuries Heart Rate, Fetal Heart Septum Cardiotonic Agents Rheumatic Heart Disease Carboxypeptidase U Stroke Volume Cardiomyopathies Echocardiography Myocardial Reperfusion Injury Heart Arrest Nephelometry and Turbidimetry Heart Valve Prosthesis Prospective Studies Ventricular Dysfunction, Left Adrenergic beta-Antagonists Heart Failure, Diastolic American Heart Association Ventricular Remodeling Intracranial Thrombosis Follow-Up Studies Fibrinopeptide B Rats, Sprague-Dawley Fibrin Fibrinogen Degradation Products Rats, Wistar Models, Cardiovascular Oxygen Consumption Chronic Disease

No FAQ available that match "blood clots after heart"